Next Article in Journal
Bordetella holmesii: Lipid A Structures and Corresponding Genomic Sequences Comparison in Three Clinical Isolates and the Reference Strain ATCC 51541
Next Article in Special Issue
Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis
Previous Article in Journal
Cellular Repair of DNA–DNA Cross-Links Induced by 1,2,3,4-Diepoxybutane
Previous Article in Special Issue
The Balloon-Based Manometry Evaluation of Swallowing in Patients with Amyotrophic Lateral Sclerosis
Review

Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis

Department of Medicine, Division of Rheumatic Diseases, Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Cleveland, OH 44106-5076, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Ali Mobasheri
Int. J. Mol. Sci. 2017, 18(5), 1084; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051084
Received: 6 March 2017 / Revised: 2 May 2017 / Accepted: 9 May 2017 / Published: 18 May 2017
(This article belongs to the Special Issue Musculoskeletal Diseases Therapy)
Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune muscle diseases with significant morbidity and mortality. This review details and updates the pathogenesis and emerging importance of myositis-specific antibodies in the development of IIMs. An increase in the understanding of how these myositis-specific antibodies play a role in IIMs has led to the further categorization of IIMs from the traditional polymyositis versus dermatomyositis, to additional subcategories of IIMs such as necrotizing autoimmune myositis (NAM). The diagnosis of IIMs, including manual muscle testing, laboratory studies, and non-invasive imaging have become important in classifying IIM subtypes and for identifying disease severity. Treatment has evolved from an era where glucocorticoid therapy was the only option to a time now that includes traditional steroid-sparing agents along with immunoglobulin therapy and biologics, such as rituximab. View Full-Text
Keywords: idiopathic; inflammation; muscle diseases idiopathic; inflammation; muscle diseases
Show Figures

Graphical abstract

MDPI and ACS Style

Mandel, D.E.; Malemud, C.J.; Askari, A.D. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis. Int. J. Mol. Sci. 2017, 18, 1084. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051084

AMA Style

Mandel DE, Malemud CJ, Askari AD. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis. International Journal of Molecular Sciences. 2017; 18(5):1084. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051084

Chicago/Turabian Style

Mandel, Dana E., Charles J. Malemud, and Ali D. Askari 2017. "Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis" International Journal of Molecular Sciences 18, no. 5: 1084. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms18051084

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop